Dubuque Bank & Trust’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,870
| Closed | -$217K | – | 252 |
|
|
2021
Q4 | $217K | Sell |
2,870
-3
| -0.1% | -$227 | 0.02% | 232 |
|
|
2021
Q3 | $322K | Hold |
2,873
| – | – | 0.04% | 188 |
|
|
2021
Q2 | $465K | Hold |
2,873
| – | – | 0.05% | 165 |
|
|
2021
Q1 | $350K | Hold |
2,873
| – | – | 0.04% | 190 |
|
|
2020
Q4 | $440K | Hold |
2,873
| – | – | 0.05% | 161 |
|
|
2020
Q3 | $240K | Buy |
+2,873
| New | +$240K | 0.04% | 183 |
|
|
2019
Q2 | – | Sell |
-2,873
| Closed | -$103K | – | 252 |
|
|
2019
Q1 | $103K | Buy |
2,873
+1,448
| +102% | +$51.9K | 0.02% | 209 |
|
|
2018
Q4 | $41K | Hold |
1,425
| – | – | 0.01% | 289 |
|
|
2018
Q3 | $63K | Hold |
1,425
| – | – | 0.01% | 246 |
|
|
2018
Q2 | $84K | Hold |
1,425
| – | – | 0.01% | 278 |
|
|
2018
Q1 | $65K | Hold |
1,425
| – | – | 0.01% | 312 |
|
|
2017
Q4 | $33K | Hold |
1,425
| – | – | 0.01% | 380 |
|
|
2017
Q3 | $25K | Hold |
1,425
| – | – | ﹤0.01% | 391 |
|
|
2017
Q2 | $23K | Hold |
1,425
| – | – | 0.01% | 386 |
|
|
2017
Q1 | $31K | Buy |
+1,425
| New | +$31K | 0.01% | 372 |
|